1Department of Transplant Immunology and Innovative Antirejection Therapies, Ospedali Riuniti, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Achieving long-term organ transplant survival without immunosuppressants is possible through microchimerism or thymus-based tolerance. Novel strategies like oral alloantigen administration show promise for indefinite graft survival.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: